Amanta Healthcare Limited Stock Price Today (NSE: AMANTA)
Fundamental Score
Amanta Healthcare Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Amanta Healthcare Limited share price today is ₹189.93, down 2.00% on NSE/BSE as of 16 September 2026. Amanta Healthcare Limited (AMANTA) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹73.75 (Cr). The 52-week high for AMANTA share price is ₹209.95 and the 52-week low is ₹92.00. At a P/E ratio of 45.66x, AMANTA is currently trading above its industry average P/E of 34.89x. The company has a Return on Equity (ROE) of 10.39% and a debt-to-equity ratio of 1.06.
Amanta Healthcare Limited Share Price Chart — NSE/BSE Historical Performance
Amanta Healthcare Limited share price chart: 23.97% return over the past month. 52-week high ₹209.95, 52-week low ₹92.00.
Amanta Healthcare Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹189.93 | ₹189.93 | ₹189.93 | ₹189.93 | 12.45K (Cr) | |
| ₹193.80 | ₹193.80 | ₹193.80 | ₹193.80 | 15.94K (Cr) | |
| ₹197.75 | ₹197.75 | ₹197.75 | ₹197.75 | 19.14K (Cr) | |
| ₹209.95 | ₹209.95 | ₹201.78 | ₹201.78 | 38.22K (Cr) | |
| ₹205.89 | ₹205.89 | ₹205.89 | ₹205.89 | 37.74K (Cr) | |
| ₹201.86 | ₹201.86 | ₹201.86 | ₹201.86 | 50.14K (Cr) | |
| ₹197.91 | ₹197.91 | ₹197.91 | ₹197.91 | 19.41K (Cr) | |
| ₹194.03 | ₹194.03 | ₹194.03 | ₹194.03 | 11.34K (Cr) | |
| ₹190.23 | ₹190.23 | ₹190.23 | ₹190.23 | 19.98K (Cr) | |
| ₹190.00 | ₹190.00 | ₹186.50 | ₹186.50 | 24.02K (Cr) |
Amanta Healthcare Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹190.80 | ₹209.95 | ₹186.50 | ₹189.93 | -0.46% | |
| ₹171.80 | ₹205.57 | ₹150.01 | ₹188.80 | +9.90% | |
| ₹158.50 | ₹189.00 | ₹153.51 | ₹168.72 | +6.45% | |
| ₹125.52 | ₹167.90 | ₹114.05 | ₹161.00 | +28.27% | |
| ₹131.13 | ₹146.78 | ₹122.00 | ₹125.51 | -4.29% | |
| ₹101.92 | ₹140.25 | ₹99.87 | ₹131.13 | +28.66% | |
| ₹99.71 | ₹102.50 | ₹92.00 | ₹99.81 | +0.10% | |
| ₹103.80 | ₹110.65 | ₹100.00 | ₹102.95 | -0.82% | |
| ₹109.00 | ₹115.00 | ₹98.25 | ₹103.33 | -5.20% | |
| ₹104.50 | ₹117.12 | ₹97.75 | ₹109.06 | +4.36% | |
| ₹121.99 | ₹124.89 | ₹99.99 | ₹106.24 | -12.91% | |
| ₹132.60 | ₹140.00 | ₹119.50 | ₹121.99 | -8.00% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Amanta Healthcare Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Amanta Healthcare Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of AMANTA across key market metrics for learning purposes.
Positive Indicators
7 factors identified
Strong Operating Margins (21.24%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Excellent EPS Growth (20.31% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (22.45% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Healthy Liquidity Position (Current Ratio: 1.69)
Observation: Strong short-term liquidity to meet obligations.
Analysis: Current ratio >1.5 indicates good working capital management.
Strong Cash Generation (₹128.70 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (63.56%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
4 factors identified
Premium Valuation Risk (P/E: 45.66x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Elevated Debt Levels (D/E: 1.06)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.
Weak Interest Coverage (2.02x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Amanta Healthcare Limited vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Amanta Healthcare Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Amanta Healthcare LimitedAmanta Healthca...Selected✓ AMANTA • 544502 | 42.3/100 | ₹189.93₹190 | ₹73.75₹73.75 | 45.66Average 45.7 Average | 10.39%Average 10.39% Average | 11.63%Average 11.63% Average | 1.06Average 1.1 Average | 22.45%Excellent 22.45% Excellent | 10.93%Good 10.93% Good | 0.00% |
Sun Pharmaceutical Industries LimitedSun Pharmaceuti... SUNPHARMA • 524715 | 66.4/100 | ₹1869.10₹1869 | ₹448453.16₹448453.16 | 37.09Average 37.1 Average | 14.74%Average 14.74% Average | 19.31%Good 19.31% Good | 0.05Excellent 0.0 Excellent | 31.64%Excellent 31.64% Excellent | 11.78%Good 11.78% Good | 0.82% |
Divi's Laboratories LimitedDivi's Laborato... DIVISLAB • 532488 | 56.3/100 | ₹9494.00₹9494 | ₹251591.00₹251591.00 | 86.14Average 86.1 Average | 16.19%Good 16.19% Good | 20.38%Excellent 20.38% Excellent | 0.00Excellent 0.0 Excellent | 5.29%Good 5.29% Good | 8.67%Good 8.67% Good | 0.41% |
Torrent Pharmaceuticals LimitedTorrent Pharmac... TORNTPHARM • 500420 | 51.4/100 | ₹4942.00₹4942 | ₹167266.93₹167266.93 | 78.95Average 78.9 Average | 27.07%Excellent 27.07% Excellent | 14.09%Average 14.09% Average | 1.76Average 1.8 Average | 11.56%Good 11.56% Good | 11.80%Good 11.80% Good | 0.76% |
Zydus Lifesciences LimitedZydus Lifescien... ZYDUSLIFE • 532321 | 74.1/100 | ₹1130.60₹1131 | ₹112833.88₹112833.88 | 25.20Average 25.2 Average | 19.74%Good 19.74% Good | 21.77%Excellent 21.77% Excellent | 0.43Excellent 0.4 Excellent | 18.76%Excellent 18.76% Excellent | 12.45%Good 12.45% Good | 0.09% |
Cipla LimitedCipla Limited... CIPLA • 500087 | 40.2/100 | ₹1371.70₹1372 | ₹110812.78₹110812.78 | 32.86Average 32.9 Average | 11.82%Average 11.82% Average | 15.67%Good 15.67% Good | 0.01Excellent 0.0 Excellent | 10.03%Good 10.03% Good | 8.01%Good 8.01% Good | 0.90% |
Laurus Labs LimitedLaurus Labs Lim... LAURUSLABS • 540222 | 34.1/100 | ₹1934.30₹1934 | ₹104500.56₹104500.56 | 95.47Average 95.5 Average | 18.19%Good 18.19% Good | 21.35%Excellent 21.35% Excellent | 0.45Excellent 0.5 Excellent | -1.89%Poor -1.89% Poor | 7.19%Good 7.19% Good | 0.13% |
Aurobindo Pharma LimitedAurobindo Pharm... AUROPHARMA • 524804 | 24.6/100 | ₹1678.90₹1679 | ₹96603.91₹96603.91 | 26.23Average 26.2 Average | 9.94%Poor 9.94% Poor | 14.54%Average 14.54% Average | 0.20Excellent 0.2 Excellent | -8.07%Poor -8.07% Poor | 6.32%Good 6.32% Good | 0.26% |
Lupin LimitedLupin Limited... LUPIN • 500257 | 83.4/100 | ₹2098.30₹2098 | ₹95944.77₹95944.77 | 17.34Average 17.3 Average | 26.90%Excellent 26.90% Excellent | 31.80%Excellent 31.80% Excellent | 0.26Excellent 0.3 Excellent | 34.39%Excellent 34.39% Excellent | 13.02%Good 13.02% Good | 0.72% |
Dr. Reddy's Laboratories LimitedDr. Reddy's Lab... DRREDDY • 500124 | 41/100 | ₹1144.10₹1144 | ₹95532.35₹95532.35 | 29.57Average 29.6 Average | 11.75%Average 11.75% Average | 14.80%Average 14.80% Average | 0.17Excellent 0.2 Excellent | 16.54%Excellent 16.54% Excellent | 12.09%Good 12.09% Good | 0.65% |
Mankind Pharma LimitedMankind Pharma ... MANKIND • 543904 | 61.5/100 | ₹2269.50₹2270 | ₹93730.35₹93730.35 | 45.86Average 45.9 Average | 12.49%Average 12.49% Average | 13.56%Average 13.56% Average | 0.39Excellent 0.4 Excellent | 10.52%Good 10.52% Good | 18.10%Excellent 18.10% Excellent | 0.04% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Limited share price448453.16 Cr
- Divi's Laboratories Limited share price251591.00 Cr
- Torrent Pharmaceuticals Limited share price167266.93 Cr
- Zydus Lifesciences Limited share price112833.88 Cr
- Cipla Limited share price110812.78 Cr
Amanta Healthcare Limited Quarterly Performance
Latest quarterly metrics for AMANTA — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
5.35%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-5.61%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
10.93%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
22.45%
Compounded annual net profit growth over 5 years
Amanta Healthcare Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for AMANTA — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Amanta Healthcare Limited Financial Statements
Annual income statement, balance sheet and cash flow for Amanta Healthcare Limited (AMANTA) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Amanta Healthcare Limited
About AMANTA (Amanta Healthcare Limited)
Amanta Healthcar is a global pharmaceutical enterprise committed to advancing health and wellness through the development, production, and distribution of high-quality sterile liqu...id products. They are dedicated to crafting a portfolio of essential pharmaceuticals designed to meet the evolving needs of patients across diverse geographical regions. Amanta's operations are underpinned by a strong commitment to research and development, focusing on innovative formulations and delivery systems to improve therapeutic outcomes. Their core values revolve around safety, efficacy, and accessibility, ensuring that their products reach those who need them most, regardless of their location. Through unwavering dedication to quality and patient-centricity, Amanta strives to be a trusted partner in global healthcare, making a tangible difference in the lives of individuals and communities worldwide. Amanta Healthcar specializes in the manufacture of a comprehensive range of parenteral solutions, meticulously produced under stringent quality control standards. Their state-of-the-art manufacturing facilities are equipped to handle various product formats, catering to the specific requirements of healthcare providers and patients. The company's dedication to sterile manufacturing techniques ensures the safety and integrity of its products, meeting and exceeding international regulatory requirements. Amanta's portfolio includes a diverse array of large-volume parenterals, small-volume parenterals, and specialized delivery systems, such as nipple-head and steriport configurations. This broad product offering positions them as a versatile supplier of essential medications for hospitals, clinics, and other healthcare institutions globally. Amanta Healthcar's commitment extends beyond pharmaceutical manufacturing, encompassing the development and production of critical medical devices and fluid therapies. This expanded focus reflects their understanding of the holistic needs of healthcare providers and their dedication to providing comprehensive solutions. Their fluid therapy segment focuses on intravenous fluids, essential for hydration, electrolyte balance, and medication delivery. By integrating medical devices and fluid therapies into their portfolio, Amanta Healthcar demonstrates a dedication to innovation and comprehensive healthcare solutions. This strategic approach allows them to offer a more integrated and streamlined approach to patient care, further solidifying their position as a valuable partner in the global healthcare landscape.
Company Details
Key Leadership
AMANTA Share Price: Frequently Asked Questions
What is the current share price of Amanta Healthcare Limited?
Amanta Healthcare Limited (AMANTA) trades at ₹189.93 on NSE and BSE. Market cap ₹73.75 (Cr). Educational data only.
What is the P/E ratio of Amanta Healthcare Limited?
Amanta Healthcare Limited has a P/E of 45.66x vs industry average 34.89x.
What is the Bull Run score for Amanta Healthcare Limited?
Amanta Healthcare Limited has a Bull Run score of 42.3/100 based on 25+ financial parameters.
Does Amanta Healthcare Limited pay dividends?
Amanta Healthcare Limited has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Amanta Healthcare Limited?
Amanta Healthcare Limited has ROE of 10.39%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Amanta Healthcare Limited?
Amanta Healthcare Limited has debt-to-equity of 1.06.
Is Amanta Healthcare Limited a good investment?
Bull Run gives Amanta Healthcare Limited a score of 42.3/100. This is not investment advice — consult a SEBI-registered advisor.